Remitly stock fell after strong Q2 growth and record profits, as analysts largely rate it a Buy despite risks from immigration policy and rising competition.
Once the money is inside a TFSA account, a $7,000 investment can become $10,000, $20,000, or considerably more with compounding, without requiring extra TFSA room.
Energy Transfer, Dillard's, and Texas Capital Bancshares are moving listings to the Texas Stock Exchange this October, testing whether lower costs can challenge the NYSE and Nasdaq.
Wesdome Gold Mines (TSE:WDO) outlined an organic growth strategy centered on expanding production and extending mine life at its Eagle River and Kiena operations through exploration, higher mill utilization and potential development of broader mining districts.
During the presentation, the company
Concentra's Q2 revenue and profit beat estimates, and all eight analysts rate it a Buy, but a leadership transition and a 75% stock rally raise valuation questions.
Clene (NASDAQ:CLNN) said it plans to submit a new drug application to the U.S. Food and Drug Administration at the beginning of the fourth quarter for CNM-Au8, its investigational treatment for amyotrophic lateral sclerosis, or ALS.
In a fireside chat at the Lytham Partners Fall 2026 Investor Confe
Inhibrx Biosciences' CEO bought $3.6 million in shares after strong Phase 2 data, as insiders accumulate stock amid heavy short interest and an upcoming FDA decision on ozekibart.
